Saturday, October 20, 2007

Relation Between Direct-to-Consumer Promotional material and Physician Diagnosing and Prescribing

The kinship between direct-to-consumer packaging expenditures and the monthly frequencies of diagnoses and prescriptions written associated with the products advertised are examined.
The analyses utilizes quasi-experimental time-series techniques.
Data from the National Ambulatory Medical Care Sum-up and Competitive Media Reporting were used to calculate monthly levels of the dependents and the individualist variables.
The dependent variables included monthly frequencies of diagnoses for the products’ FDA approved indications, medications prescribed within the advertised pharmaceutical socio-economic class, and medications prescribed for the medicinal drug advertised semantic role.
The self-employed person variables included monthly expenditures for promotion each pharmaceutical people and each medicament agentive role.
Several significant monthly relationships were found.
The diagnoses of hyperlipidemia (p = 0.008) and the amount of prescriptions written for antilipemics (p = 0.003) were positively associated with the advert using up for antilipemics.
The figure of prescriptions written for Claritin (p = 0.004) and Zoroc (p < 0.001) was positively related to the business enterprise outgo for their respective pharmaceutical classes; the amount of money of prescriptions written for Hismanal (p = 0.007), Seldane (p < 0.001), and Zantac (p = 0.004) was negatively related to the advertisement transferred property for their respective pharmaceutical classes.
The definite quantity of prescriptions written for Claritin (p = 0.005) and Zoroc (p < 0.001) was positively related to the business enterprise expending for each medicine product; the sum of money of prescriptions written for Hismanal (p = 0.049) was negatively associated with the sum of monetary system spent specifically publicity the businessperson.
This is a part of article Relation Between Direct-to-Consumer Promotional material and Physician Diagnosing and Prescribing Taken from "Generic Claritin (Loratadine)" Information Blog

No comments: